Reuters: Health News: UK cost body rejects Novartis breast cancer drug

UK cost body rejects Novartis breast cancer drug

LONDON (Reuters) - Novartis drug Afinitor, expected to be a big seller for the Swiss group, has been rejected by Britain's health cost agency NICE due...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/QEzigFWwPFw/us-novartis-britain-idUSBRE92K00020130321